Cargando…

Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design.

Detalles Bibliográficos
Autores principales: Zhang, Shuaipan, Lv, Zhizhen, Zhu, Qingguang, Sun, Wuquan, Yao, Fei, Fang, Lei, Cheng, Yanbin, Wu, Zhiwei, Fang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245505/
https://www.ncbi.nlm.nih.gov/pubmed/32446311
http://dx.doi.org/10.1186/s13063-020-04383-2
_version_ 1783537768692973568
author Zhang, Shuaipan
Lv, Zhizhen
Zhu, Qingguang
Sun, Wuquan
Yao, Fei
Fang, Lei
Cheng, Yanbin
Wu, Zhiwei
Fang, Min
author_facet Zhang, Shuaipan
Lv, Zhizhen
Zhu, Qingguang
Sun, Wuquan
Yao, Fei
Fang, Lei
Cheng, Yanbin
Wu, Zhiwei
Fang, Min
author_sort Zhang, Shuaipan
collection PubMed
description OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design.
format Online
Article
Text
id pubmed-7245505
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72455052020-05-26 Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial Zhang, Shuaipan Lv, Zhizhen Zhu, Qingguang Sun, Wuquan Yao, Fei Fang, Lei Cheng, Yanbin Wu, Zhiwei Fang, Min Trials Letter OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design. BioMed Central 2020-05-23 /pmc/articles/PMC7245505/ /pubmed/32446311 http://dx.doi.org/10.1186/s13063-020-04383-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Zhang, Shuaipan
Lv, Zhizhen
Zhu, Qingguang
Sun, Wuquan
Yao, Fei
Fang, Lei
Cheng, Yanbin
Wu, Zhiwei
Fang, Min
Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title_full Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title_fullStr Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title_full_unstemmed Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title_short Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
title_sort efficacy of liu-zi-jue in patients with 2019 novel coronavirus pneumonia (covid-19): structured summary of a study protocol for a randomized controlled trial
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245505/
https://www.ncbi.nlm.nih.gov/pubmed/32446311
http://dx.doi.org/10.1186/s13063-020-04383-2
work_keys_str_mv AT zhangshuaipan efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT lvzhizhen efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT zhuqingguang efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT sunwuquan efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT yaofei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT fanglei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT chengyanbin efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT wuzhiwei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT fangmin efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial